NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
OTC · MDRM · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Modern Mobility Aids, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Modern Mobility Aids, Inc. operates in the telehealth and telemedicine industry. It operates a telehealth platform incorporating AI and IOT to get access to healthcare regardless of location and financial status. The company was incorporated in 2007 and is based in Brampton, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$0.08$0.00 (0.0%)
nDatalyze Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
€0.03-€0.00 (-2.99%)
Biophytis S.A.’s quoted price sits in the lower half of its reported 52-week range, 79.75% below the high.
$0.02$0.00 (0.0%)
Mednow Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Verisante Technology Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.08% below the high.
$0.02$0.00 (0.0%)
EGF Theramed Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 87.43% below the high.
$0.02$0.00 (0.0%)
Imaging Dynamics Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.67% below the high.
$0.00$0.00 (0.0%)
Stemtech Corporation’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
